Australian biotech firm CSL says CEO Paul McKenzie to retire
10/02/2026 05:11
Feb 10 (Reuters) - Australia's CSL CSL.AX said on Tuesday its chief executive officer and managing director Paul McKenzie will retire effective February 11. The firm named Gordon Naylor as the interim CEO and MD. (Reporting by Rajasik Mukherjee) ((Rajasik.Mukherjee@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX